Patents Assigned to ACCURAGEN HOLDINGS LIMITED
-
Patent number: 12247252Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided. In some embodiments, methods comprise extending 3? ends of polynucleotides by adding one or more pre-determined nucleotides. In some embodiments, methods comprise use of a strand-tagging sequence.Type: GrantFiled: July 28, 2022Date of Patent: March 11, 2025Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Malek Faham, Shengrong Lin, Ling Fung Tang, Yontao Lu, Zhaohui Sun, Yingyu Wang, Li Weng
-
Patent number: 12234512Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described methods.Type: GrantFiled: February 3, 2023Date of Patent: February 25, 2025Assignee: AccuraGen Holdings LimitedInventors: Shengrong Lin, Zhaohui Sun, Grace Qizhi Zhao, Paul Ling-Fung Tang
-
Patent number: 12163184Abstract: In some aspects, the present disclosure provides methods for forming ligation products comprising single-stranded polynucleotides. Ligation products formed by various aspects of the present disclosure can be useful for various applications, including but not limited to sequence analysis. In some embodiments, the ligation products comprise cell-free polynucleotides. In some aspects, the present disclosure provides reaction mixtures, kits and complexes consistent with the methods herein.Type: GrantFiled: December 2, 2016Date of Patent: December 10, 2024Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Malek Faham
-
Patent number: 12049665Abstract: In some aspects, the present disclosure provides methods for forming ligation products comprising single-stranded polynucleotides without the need for enriching the single-stranded polynucleotides. Ligation products formed by various aspects of the present disclosure can be useful for various applications, including but not limited to sequence analysis. In some embodiments, the ligation products comprise cell-free polynucleotides. In some aspects, the present disclosure provides reaction mixtures, kits and complexes consistent with the methods herein.Type: GrantFiled: June 11, 2019Date of Patent: July 30, 2024Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Malek Faham
-
Patent number: 12043867Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided.Type: GrantFiled: November 12, 2021Date of Patent: July 23, 2024Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Malek Faham, Tobias Wittkop
-
Patent number: 11859246Abstract: In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.Type: GrantFiled: November 19, 2019Date of Patent: January 2, 2024Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Lin Fung Tang
-
Patent number: 11643683Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, or two different sheared polynucleotides as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described method.Type: GrantFiled: June 8, 2020Date of Patent: May 9, 2023Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Zhaohui Sun, Shengrong Lin
-
Patent number: 11597973Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described methods.Type: GrantFiled: July 31, 2020Date of Patent: March 7, 2023Assignee: ACCURAGEN HOLDINGS LIMITEDInventor: Paul Ling-Fung Tang
-
Patent number: 11578359Abstract: In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.Type: GrantFiled: July 13, 2020Date of Patent: February 14, 2023Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Ling Fung Tang
-
Patent number: 11427866Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided. In some embodiments, methods comprise extending 3? ends of polynucleotides by adding one or more pre-determined nucleotides. In some embodiments, methods comprise use of a strand-tagging sequence.Type: GrantFiled: May 16, 2017Date of Patent: August 30, 2022Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Malek Faham, Shengrong Lin, Ling Fung Tang, Yontao Lu, Zhaohui Sun, Yingyu Wang, Li Weng
-
Patent number: 11286519Abstract: In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.Type: GrantFiled: June 7, 2019Date of Patent: March 29, 2022Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Lin Fung Tang
-
Patent number: 11203782Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided.Type: GrantFiled: March 28, 2019Date of Patent: December 21, 2021Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Malek Faham, Tobias Wittkop
-
Patent number: 10767222Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described methods.Type: GrantFiled: December 11, 2014Date of Patent: September 8, 2020Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Shengrong Lin, Zhaohui Sun, Grace Qizhi Zhao, Paul Ling-Fung Tang
-
Patent number: 10752942Abstract: In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.Type: GrantFiled: April 6, 2018Date of Patent: August 25, 2020Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Ling Fung Tang
-
Patent number: 10724088Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, or two different sheared polynucleotides as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described method.Type: GrantFiled: October 26, 2018Date of Patent: July 28, 2020Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Zhaohui Sun, Shengrong Lin
-
Publication number: 20190323073Abstract: The present disclosure provides cell-free nucleic acid standards comprising genomic polynucleotides and methods of using cell-free nucleic acid standards comprising genomic polynucleotides for developing, optimizing, and validating cell-free nucleic acid assays.Type: ApplicationFiled: June 22, 2017Publication date: October 24, 2019Applicant: ACCURAGEN HOLDINGS LIMITEDInventors: Chia-hui LIN, Grace Qizhi ZHAO, Shengrong LIN, Li WENG
-
Patent number: 10155980Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants in a nucleic acid sample. In some embodiments, a method comprises identifying sequence differences between sequencing reads and a reference sequence, and calling a sequence difference that occurs in at least two different circular polynucleotides, such as two circular polynucleotides having different junctions, or two different sheared polynucleotides as the sequence variant. In some aspects, the present disclosure provides compositions and systems useful in the described methods.Type: GrantFiled: November 1, 2017Date of Patent: December 18, 2018Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Zhaohui Sun, Shengrong Lin